You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Amyloid Precursor Protein antibody (ab2072)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab2072? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab2072 has been referenced in 5 publications.

  1. Epis R et al. Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease. Brain 133:3323-35 (2010). WB; Mouse. PubMed: 20805102
  2. Marton O et al. Aging and exercise affect the level of protein acetylation and SIRT1 activity in cerebellum of male rats. Biogerontology 11:679-86 (2010). WB. PubMed: 20467811
  3. Rodríguez-Navarro JA et al. Parkin deletion causes cerebral and systemic amyloidosis in human mutated tau over-expressing mice. Hum Mol Genet 17:3128-43 (2008). PubMed: 18640988
  4. Lahiri DK et al. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice. J Pharmacol Exp Ther 320:386-96 (2007). PubMed: 17003227
  5. Utsuki T et al. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide. J Pharmacol Exp Ther 318:855-62 (2006). IP; Human. PubMed: 16690718

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"